These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36309402)

  • 21. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
    Sarfo FS; Le Chevalier F; Aka N; Phillips RO; Amoako Y; Boneca IG; Lenormand P; Dosso M; Wansbrough-Jones M; Veyron-Churlet R; Guenin-Macé L; Demangel C
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1237. PubMed ID: 21811642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With
    Röltgen K; Pluschke G
    Front Microbiol; 2020; 11():1018. PubMed ID: 32523571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.
    Martins TG; Trigo G; Fraga AG; Gama JB; Longatto-Filho A; Saraiva M; Silva MT; Castro AG; Pedrosa J
    PLoS Negl Trop Dis; 2012; 6(11):e1925. PubMed ID: 23209864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA Aptamer That Specifically Binds to Mycolactone and Serves as a Diagnostic Tool for Diagnosis of Buruli Ulcer.
    Sakyi SA; Aboagye SY; Otchere ID; Liao AM; Caltagirone TG; Yeboah-Manu D
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004950. PubMed ID: 27776120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
    Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH
    PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional adaptation of
    Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E
    Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844
    [No Abstract]   [Full Text] [Related]  

  • 28. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
    Hall B; Simmonds R
    Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
    Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
    J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer).
    Schütte D; Pluschke G
    Expert Opin Biol Ther; 2009 Feb; 9(2):187-200. PubMed ID: 19236249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo.
    Maman I; Tchacondo T; Kere AB; Beissner M; Badziklou K; Tedihou E; Nyaku E; Amekuse K; Wiedemann FX; Karou DS; Bretzel G
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006455. PubMed ID: 29782522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
    Zhang T; Li SY; Converse PJ; Grosset JH; Nuermberger EL
    PLoS Negl Trop Dis; 2013; 7(12):e2598. PubMed ID: 24367713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
    Bieri R; Bolz M; Ruf MT; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004450. PubMed ID: 26863011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria.
    Ruf MT; Steffen C; Bolz M; Schmid P; Pluschke G
    Virulence; 2017 Nov; 8(8):1918-1926. PubMed ID: 28873327
    [No Abstract]   [Full Text] [Related]  

  • 39. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.